Report : A-Z CDF items in Formulary 12/04/2021 01:11:35
[
Back
]
Section
Status
CDF
Name
08.01.05
Formulary
Abemaciclib Verzenios
®
08.01.05
Formulary
Acalabrutinib Calquence
®
08.01.05
Formulary
Atezolizumab Tecentriq
®
08.01.05
Formulary
Avelumab Bavencio
®
08.01.05
Restricted Use
Axicabtagene ciloleucel YESCARTA
®
08.01.01
Formulary
Bendamustine Levact
®
08.01.05
Formulary
Bevacizumab Avastin
®
08.01.05
Formulary
Binimetinib Mektovi
®
08.01.05
Formulary
Bortezomib Velcade
®
08.01
Formulary
Cabozantinib Cometriq
®
08.01.05
Formulary
Cemiplimab Libtayo
®
08.01.03
Formulary
Clofarabine Evoltra
®
08.01.05
Formulary
Crizotinib Xalkori
®
08.01.05
Formulary
Daratumumab DARZALEX
®
08.01.02
Formulary
Doxorubicin Hydrochloride Caelyx
®
08.01.05
Formulary
Durvalumab Imfinzi
®
08.01.05
Formulary
Encorafenib Braftovi
®
08.01.05
Formulary
Entrectinib Rozlytrek
®
08.03.04.01
Formulary
Fulvestrant Faslodex
®
08.01.05
Formulary
Ibrutinib Imbruvica
®
08.01.05
Formulary
Ipilimumab YERVOY
®
08.01.05
Formulary
Isatuximab Sarclisa
®
08.01.05
Formulary
Ixazomib Ninlaro
®
08.01.05
Restricted Use
Larotrectinib Vitrakvi
®
08.02.04
Formulary
Lenalidomide Revlimid
®
08.01.05
Formulary
Lutetium (177Lu) oxodotreotide Lutathera
®
08.01.03
Formulary
Nelarabine Atriance
®
08.01.05
Formulary
Niraparib Zejula
®
08.01.05
Formulary
Nivolumab Opdivo
®
08.01.05
Formulary
Olaparib Lynparza
®
08.01.05
Non Formulary
Olaratumab Lartruvo
®
08.01.05
Formulary
Palbociclib IBRANCE
®
08.01.05
Formulary
Pembrolizumab Keytruda
®
08.01.05
Formulary
Pemigatinib Pemazyre
®
08.01.05
Formulary
Ribociclib Kisqali
®
08.01.05
Formulary
Rucaparib Rubraca
®
08.01.05
Formulary
Sorafenib Nexavar
®
08.01.05
Restricted Use
Tisagenlecleucel Kymriah
®
08.01.05
Formulary
Trametinib Mekinist
®
08.01.05
Non Formulary
Vandetanib Caprelsa
®
08.01.05
Formulary
Venetoclax Venclyxto
®
Dorset